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By Noel Larrivee 
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Research involving a vaccine known as BCG, already being used in Canada and France for 
the prevention and treatment of cancer in humans, is being used effectively in the Stella 
Duncan Research Laboratories at the University of ~lantana, ~lissoula, to minimize the effects 
of tumorous growths in mice and rabbits. 
Dr. Carl L. Larson, r\t.D., professor of microbiology and director of the Stella Duncan 
Institute, said recent experiments have shown BCG to be an effective agent in the prevention 
of tuberculosis and even leprosy in small animals. 
Working under a five-year, $219,000 grant from the Public Health Service, Dr. Larson 
said animals immunized with the vaccine have been found to be resistant to a number of 
diseases--including leukemia, malignant melanoma and Herpes virus. 
"Experiments involving BCG, an active strain of tubercle bacilli, have shown it to be 
useful as an immunizing agent against a specific organism and also may be direcLed against 
a number of other non-specific organisms which grow within the cells of the host," Dr. 
Larson explained. Scientifically, BCG is known as t-.lycobacterium bovis. 
"Although BCG was originally developed to combat tuberculosis, studies at UM indicate 
it may be used to combat cancer-oriented diseases," he said. 
BCG has been employed to lower the incidence of leukemia in some test animals and pro-
long the incubation period in others. 
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"In one study of leukemia in Canadian children, there were SO per cent fe\oJer cases of 
the blood cancer in children who had been vaccinated with BCG than in an unvaccinated control 
group," Dr. Larson stated. 
"In France, BCG has been used in the treatment of leukemia for several years and in the 
United States it is being used experimentally to treat certain types of cancer." 
In the latest study at the Stella Duncan laboratories, Dr. Larson and Dr. Richard N. 
Ushijima, a Ui··i associate professor of microbiology, infected a nwnber of rabbits with Herpes 
virus (a type of venereal disease in humans) after first vaccinating a portion of the 
rabbits with BCG. 
"Although all the infected rabbits died, those having received BCG lived for a much 
longer period than those Nho had not been vaccinated," the ur.! researcher said. 
\'/hen questioned about the possible effects locally on hwnans, Dr. Larson stated there 
were already individuals in Missoula who have been vaccinated with BCG as treatment for 
cancer and the results have been encouraging. 
"The success we have had using BCG should not be interpreted as the end of our goal--
that is, to determine methods of treating cancer. \1/e hope that BCG is the key we have been 
looking for," Dr. Larson emphasized. 
In addition to the Public Health Service grant, the laboratory is supported by grants 
from the Stella Duncan Fund, the National Cancer Institute and the !'/estern Hontana Clinic 
Research Foundation. 
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